Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,885 total articles
Rocket Lab's sell-off since the SpaceX IPO has created a tradeable entry into a company that pairs rapid launch capability with spacecraft engineering and government contracts. The stock is rich by traditional multiples but operational strengths - demonstrated responsive launches and expanding space-systems revenue - give a path to justify a higher…
Adobe shares have been punished on macro and strategy fears, but the underlying cash flows, profitability and balance sheet leave room for a disciplined long trade. Entry at current levels, stop below recent low and a sensible target capture a favorable risk/reward while management executes AI product rollouts.
Avino Silver & Gold Mines (ASM) trades at $5.65 with a market cap just under $1.0B. The case: a durable silver market, shareholder-friendly actions in the past, and visible upside if management can scale output meaningfully. This is a long trade that assumes the market re-rates on production expansion; set an entry at $5.50, a stop at $4.00 and an …
HydroGraph Clean Pwr (HGRAF) is a speculative long trade that targets a volatile rebound driven by technical oversold conditions and concentrated short positioning. Entry at $3.85, stop at $2.50 and a $7.50 target reflect asymmetric upside versus defined downside. This is a high-risk, event-driven bet best sized small and watched closely for diluti…
Fair Isaac (FICO) has re-emerged as a compelling long after a recent pullback. Strong earnings, near-$1B free cash flow and a P/E in the mid-30s create a valuation that is attractive given the company’s high returns on assets and recurring revenue mix. This trade proposes a long entry at $1,140 with a $1,500 target over 180 trading days and a $980 …
Nvidia's leadership in AI inference and record data-center revenue give the company strong secular tailwinds. If improving China access materializes, it would add incremental growth without meaningfully changing the already-robust cash-flow profile. Trade plan: buy on or near $200.66, stop at $170.00, target $300.00 over a 180-trading-day horizon.
ServiceNow is a high-quality enterprise SaaS business that has pulled back from its 52-week high and now trades at attractive entry levels for investors willing to tolerate near-term macro and sentiment noise. The company's Now Platform, growing AI commitments and strong free cash flow offer a catalyst-rich path to a return to double-digit revenue …
Abercrombie & Fitch is trading at a single-digit P/E and attractive EV multiples while reporting steady top-line growth and strong free cash flow. Recent beats, a Hollister collaboration with Target and explicit buyback plans provide near-term catalysts. This trade idea outlines an actionable long with entry, stop and target for a 180-trading-day h…
Danaos (DAC) offers a rare combination for the shipping space: sizeable contracted revenue backlog, strong reported liquidity, and a bargain-bin valuation. The stock trades at a low PE (4.5) and PB (0.59) against a $4.3B contracted backlog and $1.4B of liquidity. We lay out a mid-term trade to capture re-rating and execution on new charters while e…
British American Tobacco (BTI) offers a 5%+ yield, reasonable valuation (P/E ~13), and diversified product exposure (oral pouches, smoke-free initiatives, selective cannabis investments). For investors looking to step away from AI-driven volatility, BTI is a pragmatic long trade: buy for income and a steady upside to $68 over the next 180 trading d…
Design Therapeutics reported dose-dependent clinical improvements and robust biomarker lifts from four-week IV data in RESTORE-FA (DT-216P2). With management signaling movement toward registrational development and multiple programs advancing, DSGN ($13.81) offers an asymmetric risk/reward for a long-term trade. This plan targets upside toward $18 …
Albemarle (ALB) trades under its 50-day trend and looks oversold near $148, but the company’s light leverage (debt/equity 0.19), positive free cash flow ($577M), and strong EV exposure argue for a long trade into 2026 demand reacceleration. We outline an actionable plan with entry, stop and target, plus what would invalidate the thesis.
JBS trades at a single-digit P/E with operational tailwinds from record beef prices and corporate actions that trim refinancing risk. We keep a BUY stance but flag a clear break point in 2H26 tied to margin pressure or renewed liquidity stress. Actionable entry, stop and target provided for a long-term trade.
Logitech's mix shift toward higher-margin enterprise video and sustained strength in gaming peripherals leave the stock attractively positioned at current levels. Solid profitability (ROE ~32%), nearly $1.0B free cash flow, and a reasonable P/E (~21.7) justify a buy. Trade plan: enter $102.37, stop $95.00, target $125.00 on a long-term (46-180 trad…
Charter (CHTR) has seen a brutal re-rating on subscriber worries and a messy quarter, but fundamentals — $4.3B free cash flow, EPS north of $40, and EV/EBITDA ~5.2 — argue the market is pricing a total collapse that is unlikely. This trade targets a recovery as noise fades, the Cox transaction resolves, and churn stabilizes. Entry $132.00, stop $12…
Paycom has shifted from a hyper-growth valuation to a lower-multiple, cash-generative software company. With a market cap near $6.06B, FCF of $445.9M, expanding margins and aggressive buybacks, the risk/reward now favors a long position. We lay out an entry at $127.22, a stop at $105.00 and a target of $165.00 over ~180 trading days.
Microsoft is trading near its 52-week low while still generating ~ $73B of free cash flow, a 22x P/E and returning capital to shareholders. Technical oversold signals and a string of AI infrastructure catalysts create a limited-time buying opportunity. This trade idea lays out a concrete entry, stop and target with a mid-term time horizon and balan…
Primo Brands sits in a predictable corner of consumer staples: packaged and dispensed water. Rising at-home consumption, stickiness of refillable home-jug customers, and a modest margin recovery make the stock a tactical mid-term buy. This trade targets re-rating catalysts over the next 45 trading days while keeping risk manageable with a tight sto…
Xerox (XRX) looks actionable after recent Q1'26 developments. The stock is trading at a low multiple to free cash flow (P/FCF ~5.3) with reported free cash flow of $77M, a market cap around $409M and a dividend yield near 3.2%. Technicals show a constructive longer-term trend while short-term momentum is mixed - a defined entry, stop and target giv…
Euronet Worldwide (EEFT) is a cash-generative payments and ATM infrastructure play trading at mid-single digit multiples relative to earnings and EBITDA. Management is targeting 10-15% earnings growth in 2026 and has signed a strategic deal to acquire CrediaBank's merchant acquiring business in Greece, adding scale and a digital wallet roadmap. We …
Alphabet's position as an AI infrastructure anchor, combined with material Google Cloud growth and a defensive balance sheet, justifies a tactical upgrade to long. Entry at $343.08 with a target at $408.61 and a $325 stop reflects upside to recent highs while respecting macro and execution risk.
Hasbro is often pigeonholed as a toymaker. That’s short-sighted. The company’s Wizards of the Coast franchises, licensing engine and entertainment push give it non-cyclical, high-margin optionality. At $83.92 the stock offers a compelling mid-term trade: buy for a targeted rebound to $100 over the next 45 trading days, with a conservative $75 stop …
RIOFF is trading below its recent moving averages and appears to be priced as a capital-hungry developer despite milestones that could justify a producer multiple. We outline a long trade with an entry at $1.70, a stop at $1.40 and a $2.60 target over a 46-180 trading day horizon, backed by balance-sheet signals, a recent C$23M financing and elevat…
Galectin Therapeutics (GALT) just cleared an important de-risking hurdle: formal alignment with regulators and fresh EASL 2026 data showing belapectin reduced new varices and improved liver stiffness. With the stock trading at ~ $3.89 and a market cap of roughly $256M, the risk-reward now favors a long trade on a controlled entry. This idea lays ou…
Texas Roadhouse (TXRH) benefits from its steak-forward menu, strong comp momentum and low leverage — factors that let it navigate higher beef costs while smaller rivals struggle. With momentum, attractive cash flow and a dividend, I recommend a tactical long with an entry at $183.89, a $200 target and a $170 stop loss over a 180 trading-day horizon…
